Radiotherapy utilisation in lung cancer in New Zealand: Disparities with optimal rates explained

New Zealand Medical Journal

Volumn 122, Issue 1306, 2009, Pages 43-54

  Stevens, Graham ^a   Stevens, Wendy ^a   Purchuri, Sudha ^b   Kolbe, John ^a   Cox, Brian ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; RESOURCE MANAGEMENT; SURVIVAL RATE; TREATMENT REFUSAL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; NEOPLASM STAGING; NEW ZEALAND; PNEUMONECTOMY; PROBABILITY; RADIOTHERAPY, ADJUVANT; REGISTRIES; RETROSPECTIVE STUDIES; RURAL POPULATION; SURVIVAL ANALYSIS; URBAN POPULATION;

EID: 71649110010     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Delaney G, Barton M, Jacob S and Jalaludin B. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol. 2003;4:120-128. (Pubitemid 36193172)
2. Tyldesley S, Boyd C, Scheulze K, Walker H and MacKillop W. Estimating the need for radiotherapy for lung cancer: An evidence-based, epidemiologic approach. Int J Rad Oncol Bio Phys. 2001;49(4):973-985. (Pubitemid 32184604)
3. Cancer in Scotland: Radiotherapy Activity Planning for Scotland 2011-2015. The Scottish Government Publication, January 2006. http://www.scotland.gov.uk/Publications/2006/01/24131719/0
4. Scenario Subgroup. Predicting future demand for radiotherapy: A report for the National Radiotherapy Advisory Group, UK. Version 3, January 2007. http://www.cancer.nhs.uk/documents/nrag-files/ Scenario%20Sub%20Group%20report%20- %20Jan%2007%20-%20fin.pdf
5. Scenario Subgroup, Advice to the National Radiotherapy Advisory Group. Appendix A - Treatment trees. http://www.cancer.nhs.uk/documents/nrag-files/ Scenario%20%20Report%20Appendix%20A %20-%Treatment%20Trees%20-%20fin.pdf
6. New Zealand Health Information Service. Cancer New Registrations and Deaths 2002. Ministry of Health, Wellington, June, 2006. www.nzhis.govt.nz/ publications/cancer02.pdf
7. New Zealand Health Information Service. Mortality and Demographic Data 2002 and 2003. Ministry of Health, Wellington, June, 2006. http://www.nzhis. govt.nz/publications/mortality.html
8. Delaney G, Jacob S, Featherstone C and Barton M. The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 2005;104(6): 1129-1137. (Pubitemid 41278947)
9. Stevens W, Stevens G, Kolbe J, Cox B. Lung cancer in New Zealand: Patterns of secondary care and implications for survival. J Thorac Oncol. 2007; 2(6):481-493. (Pubitemid 47189283)
10. Stevens W, Stevens G, Kolbe J, Cox B Management of stage I/II NSCLC in a NZ study: divergence from international practice and recommendations. Int Med J, In press;
11. On line version available. Int Med J, 20 Feb 2008: doi:10.1111/j.1445- 5994.2007.01523.x
12. Stevens W, Stevens G, Kolbe J, Cox B. Ethnic differences in the management of lung cancer in New Zealand. J Thorac Oncol. 2008;3(3):237-244. (Pubitemid 351654322)
13. Stevens W, Stevens G, Kolbe J, Cox B. Varied routes of entry into secondary care and delays in the management of lung Cancer in New Zealand, Asia Pacific J Clin Oncol, 2008, 4(2): 98-106. (Pubitemid 351803041)
14. Stevens W, Stevens G, Kolbe J, Cox B. Comparison of New Zealand Cancer Registry data with an independent lung cancer audit. N Z Med J. 2008,121(1276). (Pubitemid 351902666)
15. Shrout P and Fleiss J. Intraclass correlation: Uses in assessing rater reliability. Psychological Bulletin, 1979;86(2):420-428.
16. Garson D. Reliability Analysis. Statnotes. North Carolina State University, 2007.
17. Inter-rater reliability: Kappa On-line calculator. Vassar Stats. http://faculty.vassar.edu/lowry/kappa.html
18. New Zealand Health Information Service. Cancer Patient Survival Covering the Period 1994 to 2003. Ministry of Health, Wellington, 2006. http://www.nzhis.govt.nz/moh.nsf/pagesns/129/$File/cancersurvival94-03. pdf
19. Muers M, Higgins B, Johnston I, Rudolf M, Pearce S and Pickles H. BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. Thorax, 1998;53(1S):1S-8S. (Pubitemid 28322331)
20. Vinod S and Barton M. Actual versus optimal utilization of radiotherapy in lung cancer: Where is the shortfall? Asia-Pac J Clin Oncol 2007; 3:30-36.
21. Moller T, Brorsson B, Ceberg J, Frodin J, Lindholm C, Nylen U and Perfekt R. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol. 2003, 42: 387-410.
22. O'Rourke N, Edwards R. Lung cancer treatment waiting times and tumour growth. J Clin Oncol 2000;12:141-144 (Pubitemid 30458749)
23. Blamey R, Rickard M, Wright J, Alberson R, Lawson-Te Aho K, et al. Report of the quality assurance review of the Otago-Southland breast cancer screening pilot programme, 1996.
24. New Zealand Health Information Service. Cancer Patient Survival Covering the Period 1994 to 2003. Ministry of Health, Wellington, 2006. http://www.nzhis.govt.nz/publications/cancersurvival9403.pdf
25. Public Health Agency of Canada. Canadian Cancer Statistics, 2006. Canadian Cancer society, National Cancer Institute of Canada, Statistic Canada, Provincial Territorial Cancer Registries and the Public Health Agency of Canada, Canada, 2006. http://www.cancer.ca/vgn/images/portal/cit-86751114/31/21/ 935505792cw-2006stats-en.pdf